» Articles » PMID: 32292261

Biological and Epidemiological Trends in the Prevalence and Mortality Due to Outbreaks of Novel Coronavirus COVID-19

Overview
Date 2020 Apr 16
PMID 32292261
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The novel coronavirus (Covid-19) infection outbreak has posed a major threat to the international health system and economy. This study is aimed at investigating the biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus (COVID-19) infections. The data on the global outbreak of COVID-19, were obtained from World Health Organization (WHO), Worldometer, Centers for Disease Control and Prevention (CDC), and research institutes. The information was also recorded from research documents published in global scientific journals indexed in Pub Med and Institute of Scientific Information (ISI) Web of Science on the trends in the prevalence and mortality due to COVID-19 infection outbreaks. The results show rising trends in the transmission, prevalence and mortality rate due to coronavirus COVID-19. During the period of December 29, 2019 through March 31, 2020, it has infected 750,890 people worldwide, resulting in 36,405 deaths with a mortality rate of 4.84%. The infections were more frequent among male gender over 60 years of age. The mean growth rate index for total number of cases from January 23 to March 31, 2020 was 1.20 and growth rate index for mortality rate was 1.12. There was a positive association between the prevalence and mortality rate (R = 0.996). The novel coronavirus COVID-19 is highly contagious and has affected a large number of people worldwide. It is still spreading with mutable prevalence and mortality outbreak trends. The global health officials have taken priority measures to prevent further outbreaks of this emerging pathogen across the globe. However, the rising number of cases and mortality risk estimates are demonstrating that enhanced public health mediations, good hygienic conditions, social distancing, and movement limitations may control the COVID-19 epidemics.

Citing Articles

COVID-19: vaccination, therapeutics and a review of the science and public health.

Shah S, Bhandari K, Shah A, Chaurasiya G Ann Med Surg (Lond). 2024; 86(9):5343-5353.

PMID: 39239001 PMC: 11374161. DOI: 10.1097/MS9.0000000000002374.


Preventive behaviors of respiratory infections in staff of hospital in Kazeroon, Fars, Iran: An application of protection motivation theory.

Rakhshani T, Shafiei Z, Taravatmanesh S, Kashfi S, Afzali Harsini P, Kamyab A Clin Respir J. 2024; 18(6):e13791.

PMID: 38888197 PMC: 11184572. DOI: 10.1111/crj.13791.


Low serum lipase levels in mothers of children with stunted growth indicate the possibility of low calcium absorption during pregnancy: A cross-sectional study in North Sumatra, Indonesia.

Sari D, Amelia R, Masyithah D, Tantrakarnapa K PLoS One. 2024; 19(6):e0298253.

PMID: 38843179 PMC: 11156305. DOI: 10.1371/journal.pone.0298253.


Antibody Response to SARS-CoV-2 Vaccination in Heart Failure Patients: Retrospective Single-Center Cohort Study.

Ergi D, Kahraman U, Akkus G, Durmaz S, Balcioglu O, Engin C Diagnostics (Basel). 2023; 13(22).

PMID: 37998596 PMC: 10670598. DOI: 10.3390/diagnostics13223460.


Risk Factors for the Impairment of Ambulation in Older People Hospitalized with COVID-19: A Retrospective Cohort Study.

Gouveia E Silva E, Schmitt A, de Godoy C, de Oliveira D, Tanaka C, Toufen Jr C Int J Environ Res Public Health. 2023; 20(22).

PMID: 37998288 PMC: 10671138. DOI: 10.3390/ijerph20227057.


References
1.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

2.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

3.
Nassar M, Bakhrebah M, Meo S, Alsuabeyl M, Zaher W . Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. Eur Rev Med Pharmacol Sci. 2018; 22(12):3913-3918. DOI: 10.26355/eurrev_201806_15276. View

4.
Meo S, Alhowikan A, Al-Khlaiwi T, Meo I, Halepoto D, Iqbal M . Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020; 24(4):2012-2019. DOI: 10.26355/eurrev_202002_20379. View

5.
Nassar M, Bakhrebah M, Meo S, Alsuabeyl M, Zaher W . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci. 2018; 22(15):4956-4961. DOI: 10.26355/eurrev_201808_15635. View